Agilent Technologies Inc

NYSE: A
$145.00
+$0.84 (+0.6%)
Closing price April 11, 2024
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
Here is an assessment of how safe the dividend at Abbott Laboratories appears to be based on a variety of metrics, including its status as a Dividend Aristocrat.
Friday's top analyst upgrades and downgrades included Agilent, Boeing, General Electric, Lockheed Martin, Meta Platforms, Micron Technology, Redfin, Salesforce, Trade Desk, Unity Software and Workday.
Thursday's additional top analyst upgrades and downgrades were on Agilent Technologies, KB Home, Kosmos Energy, Lennar, Snowflake, Thermo Fisher Scientific and more.
Citigroup is moving to the sidelines on a few stocks after they reported their most recent quarterly results.
Thurs day's top analyst upgrades and downgrades included Ally Financial, APA, Caesars Entertainment, Chevron, Danaher, Datadog, EOG Resources, EQT, Harley-Davidson, Las Vegas Sands, Netflix, Pioneer...
Friday's top analyst upgrades and downgrades included Agilent Technologies, Bunge, Duolingo, Dynatrace, Emerson Electric, Kohl’s, Lamar Advertising, Oshkosh, Regions Financial, Splunk, Spotify, XPO...
Thursday's top analyst upgrades and downgrades included Agilent Technologies, Apple, Best Buy, Coinbase Global, CrowdStrike, Equitable, Intuit, Lululemon Athletica, Okta, Petco Health and Wellness,...
Monday’s additional top analyst upgrades and downgrades included Agilent Technologies, Barrick Gold, Deere, Kellogg, Marathon Oil, Newmont, Penn National Gaming, Spotify Technology and Verizon...
Wednesday's top analyst upgrades and downgrades included Allstate, Chevron, Dollar Tree, Etsy, General Electric, Home Depot, MGM Resorts, Overstock.com, Progressive, Spotify, Zoom Video...
Merck, Nike and these other top companies are expected to lift the dividends they pay to shareholders, and their stocks are rated Buy across Wall Street, making them excellent total return candidates.
These four top companies are hitting on all cylinders, have earnings out of the way for the quarter and their stocks look poised to head higher the rest of 2021. Best of all, Goldman Sachs just...
Thursday's top analyst upgrades and downgrades included Agilent Technologies, Carnival, Clorox, Darden Restaurants, Pinduoduo, QuantumScape, Royal Dutch Shell and Williams-Sonoma.
Wednesday's top analyst upgrades and downgrades included Agilent Technologies, Bausch Health, Bluebird Bio, Cree, Facebook, Fortive, Oshkosh and Palantir Technologies.
Wednesday's top analyst upgrades and downgrades included Agilent Technologies, Cree, Deere, Gilead Sciences, Home Depot, Kohl's, Nordstrom, Walmart and Walt Disney.
Friday's top analyst upgrades and downgrades included Agilent Technologies, Aurora Cannabis, Best Buy, Box, Marvell Technology, Nvidia, Palo Alto Networks, Roku, Splunk and TJX Companies.